Health Technology Assessments (HTAs)

Disclaimer: The South African Medical Technology Industry Association (SAMED) provides this content as a complimentary service. The content is not a substitute for appropriate legal advice and is not binding on SAMED. SAMED, its board members, committees, employees and members, will not be responsible for any inaccuracies or omissions, or, liable for any damages or loss of whatsoever nature suffered by any person as a result of relying on or using the content provided.

Medscheme Health Technology Assessments and Reimbursement
October 2020
Christeen Keyter who is the Advanced Specialist: Health Technology Assessment in the Health Policy Unit at Medscheme provided an outline of the HTA and reimbursement processes for Medscheme at a SAMED Market Access Forum. The presentation covers:

  • Medscheme reimbursement and HTA processes
  • An organogram of the HTA/reimbursement team
  • Policy and processes on price increases, price reviews and price benchmarking
  • Special Covid-19-related requirements,

Discovery Health Health Technology Assessments and Reimbursements
November 2020
The Centre for Clinical Evidence team at Discovery Health provided an overview of their HTA and reimbursement processes a SAMED Market Access Forum . The presentation covers:

  • Discovery PIN Process & Price Increases; Kershnee Chetty, Head: Surgical Risk Unit
  • The HTA Process & Supplier Journey; Niri Bhimsan, Head: Health Technology Assessment
  • Overall functions of the Clinical Policy Unit; Lindiwe Mbekeni, Clinical Specialist; Head of the Clinical Policy Unit